Showing results (211-220 of 253) with videos related to

Sort By:
Pageof 26
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapyCarla S Walti, Andrea N Loes, Kiel Shuey, et al.
Cancer Cell|January 9, 2024
Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapiesErica T Goddard, Miles H Linde, Shivani Srivastava, et al.
JCI Insight|April 29, 2021
Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignanciesCarla S Walti, Elizabeth M Krantz, Joyce Maalouf, et al.
Nature Communications|April 6, 2026
Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody responseStosh Ozog, Elizabeth M Krantz, Karyn Tindbaek, et al.
Journal for Immunotherapy of Cancer|October 27, 2021
Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy: a prospective observational studyCarla S Walti, Andrea N Loes, Kiel Shuey, et al.
Transplantation and Cellular Therapy|May 22, 2026
Outcomes of Hematopoietic Cell Transplantation in Patients with Plasmablastic LymphomaTaha Al-Juhaishi, Kwang Woo Ahn, Tiening Chen, et al.
Nature Biotechnology|November 1, 2022
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapyAlfredo Quijano-Rubio, Aladdin M Bhuiyan, Huilin Yang, et al.
Journal for Immunotherapy of Cancer|October 16, 2014
Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cellsSeth M Pollack, Robin L Jones, Erik A Farrar, et al.
Blood|September 27, 2021
Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remissionMazyar Shadman, Marcelo Pasquini, Kwang Woo Ahn, et al.
Pageof 26